Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PCDH12 FAT2 HMCN2 PCDH15 NECTIN4 ROBO3 DSCAM PCDHGA3 PCDHA7 PTPRT DCHS1 CDH5 PCDH8	2.43e-08	187	193	13	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	PCDH12 FAT2 HMCN2 PCDH15 NECTIN4 ROBO3 DSCAM PCDHGA3 PCDHA7 PTPRT DCHS1 IL1RAP CDH5 PCDH8	1.58e-06	313	193	14	GO:0098742
GeneOntologyCellularComponent	perineuronal net	ACAN BCAN VCAN	8.73e-05	10	192	3	GO:0072534
GeneOntologyCellularComponent	anchoring junction	ZNF185 MPDZ THSD1 PCDH12 PLEKHG5 HNRNPK IQGAP1 FNDC1 FAT2 AHNAK SVIL NECTIN4 DNMBP MPP1 HSPG2 ANXA6 AFAP1 FLCN SCRIB CDH5 FRMD5 ATP6V0A2	9.59e-05	976	192	22	GO:0070161
GeneOntologyCellularComponent	perisynaptic extracellular matrix	ACAN BCAN VCAN	1.19e-04	11	192	3	GO:0098966
GeneOntologyCellularComponent	synapse-associated extracellular matrix	ACAN BCAN VCAN	2.04e-04	13	192	3	GO:0099535
GeneOntologyCellularComponent	cell-cell junction	MPDZ PCDH12 PLEKHG5 IQGAP1 FNDC1 FAT2 AHNAK NECTIN4 DNMBP MPP1 ANXA6 FLCN SCRIB CDH5 FRMD5	3.85e-04	591	192	15	GO:0005911
GeneOntologyCellularComponent	Golgi lumen	ACAN MUC20 HSPG2 MUC16 BCAN VCAN	5.14e-04	109	192	6	GO:0005796
Domain	Cadherin_CS	PCDH12 FAT2 PCDH15 PCDHGA3 PCDHA7 DCHS1 CDH5 PCDH8	1.75e-05	109	193	8	IPR020894
Domain	SPOC_C	SPOCD1 DIDO1 PHF3	2.12e-05	6	193	3	IPR012921
Domain	SPOC	SPOCD1 DIDO1 PHF3	2.12e-05	6	193	3	PF07744
Domain	CADHERIN_1	PCDH12 FAT2 PCDH15 PCDHGA3 PCDHA7 DCHS1 CDH5 PCDH8	2.28e-05	113	193	8	PS00232
Domain	Cadherin	PCDH12 FAT2 PCDH15 PCDHGA3 PCDHA7 DCHS1 CDH5 PCDH8	2.28e-05	113	193	8	PF00028
Domain	CADHERIN_2	PCDH12 FAT2 PCDH15 PCDHGA3 PCDHA7 DCHS1 CDH5 PCDH8	2.43e-05	114	193	8	PS50268
Domain	-	PCDH12 FAT2 PCDH15 PCDHGA3 PCDHA7 DCHS1 CDH5 PCDH8	2.43e-05	114	193	8	2.60.40.60
Domain	CA	PCDH12 FAT2 PCDH15 PCDHGA3 PCDHA7 DCHS1 CDH5 PCDH8	2.59e-05	115	193	8	SM00112
Domain	Cadherin-like	PCDH12 FAT2 PCDH15 PCDHGA3 PCDHA7 DCHS1 CDH5 PCDH8	2.76e-05	116	193	8	IPR015919
Domain	Cadherin	PCDH12 FAT2 PCDH15 PCDHGA3 PCDHA7 DCHS1 CDH5 PCDH8	3.12e-05	118	193	8	IPR002126
Domain	TFS2M	SPOCD1 DIDO1 PHF3	3.69e-05	7	193	3	SM00510
Domain	TFIIS_M	SPOCD1 DIDO1 PHF3	3.69e-05	7	193	3	PF07500
Domain	TFIIS_cen_dom	SPOCD1 DIDO1 PHF3	5.86e-05	8	193	3	IPR003618
Domain	-	SPOCD1 DIDO1 PHF3	5.86e-05	8	193	3	1.10.472.30
Domain	TFIIS_CENTRAL	SPOCD1 DIDO1 PHF3	5.86e-05	8	193	3	PS51321
Domain	Dopey_N	DOP1B DOP1A	1.06e-04	2	193	2	PF04118
Domain	Dopey_N	DOP1B DOP1A	1.06e-04	2	193	2	IPR007249
Domain	ChSh	CBX3 CBX1	3.17e-04	3	193	2	SM00300
Domain	Chromo_shadow_dom	CBX3 CBX1	3.17e-04	3	193	2	IPR008251
Domain	TECPR	TECPR2 HERC2	3.17e-04	3	193	2	SM00706
Domain	Lipin_N	LPIN1 LPIN3	3.17e-04	3	193	2	IPR007651
Domain	Lipin_mid	LPIN1 LPIN3	3.17e-04	3	193	2	IPR031703
Domain	Lipin_N	LPIN1 LPIN3	3.17e-04	3	193	2	PF04571
Domain	Lipin_mid	LPIN1 LPIN3	3.17e-04	3	193	2	PF16876
Domain	Chromo_shadow	CBX3 CBX1	3.17e-04	3	193	2	PF01393
Domain	Beta-propeller_rpt_TECPR	TECPR2 HERC2	3.17e-04	3	193	2	IPR006624
Domain	DH_1	NET1 PLEKHG5 DNMBP ARHGEF19 ARHGEF12	4.84e-04	63	193	5	PS00741
Domain	WD40_repeat	BCAS3 TECPR2 HERC2 WDR62 ATG16L2 NWD1 WDR36 WDFY4 TLE3 KCTD3	5.50e-04	272	193	10	IPR001680
Domain	G2F	HMCN2 NID2	6.29e-04	4	193	2	PF07474
Domain	NIDOGEN_G2	HMCN2 NID2	6.29e-04	4	193	2	PS50993
Domain	GFP	HMCN2 NID2	6.29e-04	4	193	2	IPR009017
Domain	G2_nidogen/fibulin_G2F	HMCN2 NID2	6.29e-04	4	193	2	IPR006605
Domain	WD_REPEATS_1	BCAS3 TECPR2 HERC2 WDR62 ATG16L2 NWD1 WDR36 WDFY4 TLE3 KCTD3	6.51e-04	278	193	10	PS00678
Domain	WD_REPEATS_2	BCAS3 TECPR2 HERC2 WDR62 ATG16L2 NWD1 WDR36 WDFY4 TLE3 KCTD3	6.69e-04	279	193	10	PS50082
Domain	WD_REPEATS_REGION	BCAS3 TECPR2 HERC2 WDR62 ATG16L2 NWD1 WDR36 WDFY4 TLE3 KCTD3	6.69e-04	279	193	10	PS50294
Domain	RhoGEF	NET1 PLEKHG5 DNMBP ARHGEF19 ARHGEF12	6.88e-04	68	193	5	SM00325
Domain	EGF	ADAM11 GPR179 FAT2 HSPG2 NID2 BCAN ADAM22 VCAN TNXB	7.76e-04	235	193	9	SM00181
Domain	EGF_3	ADAM11 FAT2 HMCN2 HSPG2 NID2 BCAN ADAM22 VCAN TNXB	7.76e-04	235	193	9	PS50026
Domain	RhoGEF	NET1 PLEKHG5 DNMBP ARHGEF19 ARHGEF12	7.86e-04	70	193	5	PF00621
Domain	DH_2	NET1 PLEKHG5 DNMBP ARHGEF19 ARHGEF12	7.86e-04	70	193	5	PS50010
Domain	-	NET1 PLEKHG5 DNMBP ARHGEF19 ARHGEF12	8.39e-04	71	193	5	1.20.900.10
Domain	DH-domain	NET1 PLEKHG5 DNMBP ARHGEF19 ARHGEF12	8.39e-04	71	193	5	IPR000219
Domain	Ig-like_fold	LILRB1 FNDC1 HMCN2 PKHD1 NECTIN4 CAMTA1 ROBO3 HSPG2 COL7A1 LILRA3 DSCAM BCAN PTPRT VCAN WFIKKN2 IL1RAP TNXB	1.08e-03	706	193	17	IPR013783
Domain	Apc4_WD40_dom	WDR62 NWD1 WDR36	1.09e-03	20	193	3	IPR024977
Domain	ANAPC4_WD40	WDR62 NWD1 WDR36	1.09e-03	20	193	3	PF12894
Domain	EGF-like_dom	ADAM11 FAT2 HMCN2 HSPG2 NID2 BCAN ADAM22 VCAN TNXB	1.17e-03	249	193	9	IPR000742
Domain	-	LILRB1 FNDC1 PKHD1 NECTIN4 CAMTA1 ROBO3 HSPG2 COL7A1 LILRA3 DSCAM BCAN PTPRT VCAN WFIKKN2 IL1RAP TNXB	1.48e-03	663	193	16	2.60.40.10
Domain	IG	LILRB1 HMCN2 NECTIN4 ROBO3 HSPG2 LILRA3 DSCAM BCAN PTPRT VCAN WFIKKN2 IL1RAP	1.48e-03	421	193	12	SM00409
Domain	Ig_sub	LILRB1 HMCN2 NECTIN4 ROBO3 HSPG2 LILRA3 DSCAM BCAN PTPRT VCAN WFIKKN2 IL1RAP	1.48e-03	421	193	12	IPR003599
Domain	LNS2	LPIN1 LPIN3	1.55e-03	6	193	2	IPR013209
Domain	LNS2	LPIN1 LPIN3	1.55e-03	6	193	2	SM00775
Domain	LNS2	LPIN1 LPIN3	1.55e-03	6	193	2	PF08235
Domain	LNS2/PITP	LPIN1 LPIN3	1.55e-03	6	193	2	IPR031315
Domain	EGF-like_CS	ADAM11 FAT2 HMCN2 HSPG2 NID2 BCAN ADAM22 VCAN TNXB	1.61e-03	261	193	9	IPR013032
Domain	EGF_2	ADAM11 FAT2 HMCN2 HSPG2 NID2 BCAN ADAM22 VCAN TNXB	1.79e-03	265	193	9	PS01186
Domain	WD40	BCAS3 TECPR2 WDR62 ATG16L2 NWD1 WDR36 WDFY4 TLE3 KCTD3	1.93e-03	268	193	9	SM00320
Domain	EGF	FAT2 HSPG2 NID2 BCAN VCAN TNXB	1.99e-03	126	193	6	PF00008
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EME1 PPAN ERCC5 GBF1 ACACA MYO1C MAP4 HNRNPK IQGAP1 EFTUD2 PHC3 MDN1 MAGED2 SVIL OXSR1 DNMBP CSTF2T WDR62 DIDO1 NCOR2 KMT2D PHF3 TLE3 SCRIB SNRNP200 HDLBP	5.67e-13	774	200	26	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	GADD45B GBF1 ACACA BCAS3 ANKLE1 ANKHD1 PLEKHG5 EHBP1L1 MDN1 AHNAK HERC2 DNMBP ABCC10 HSPG2 ARHGEF19 SZT2 APEH FRYL LARS2 FAAP100 FAM83H TRAK1 LPIN3 NCOR2 KMT2D BTBD7 FLCN CABIN1	5.36e-11	1105	200	28	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MCC DDN CBX3 MPDZ LMTK3 HNRNPK IQGAP1 EFTUD2 CEP170 MDN1 MAGED2 SVIL HERC2 DSCAM ARHGEF12 DIDO1 ATF6B ADAM22 NCOR2 TBK1 PDE4DIP DCHS1 SCRIB CABIN1 PCDH8	3.84e-10	963	200	25	28671696
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DENND4A ACACA MAP1A MPDZ MAGED2 WDR62 KIF26B ARHGEF12 TRAK1 AFAP1 FAM193A SCRIB	3.67e-09	209	200	12	36779422
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DENND4A GBF1 ACACA NET1 MAP4 BCAS3 MPDZ CEP170 MDN1 AHNAK SVIL DNMBP WDR62 DOP1B KIF26B FRYL FAM83H TRAK1 LPIN3 PHF3 SCRIB DOP1A	6.25e-09	861	200	22	36931259
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ACACA MAP1A MAP4 ZNF185 DACH1 HNRNPK CEP170 MAGED2 AHNAK AHCY PDS5A OXSR1 NCOR2 PHF3 TLE3 HDLBP	7.55e-09	444	200	16	34795231
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ACACA MAP4 DACH1 MPDZ ANKHD1 HNRNPK CEP170 AHNAK CSTF2T TTF2 TBC1D15 DIDO1 KMT2D PHF3 SCRIB SNRNP200 HDLBP	2.35e-08	549	200	17	38280479
Pubmed	BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.	MYO1C MAP1A MAP4 ANKHD1 EFTUD2 AHNAK WDR62 NCOR2 SNRNP200 HDLBP	2.67e-08	156	200	10	32850835
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ACACA MYO1C MAP4 CBX3 ANKHD1 IQGAP1 CEP170 MDN1 AHNAK PDS5A HERC2 WDR36 ANXA6 DIDO1 FRYL PHF3 SNRNP200 HDLBP	5.22e-08	653	200	18	22586326
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ACACA MAP1A MAP4 CBX3 ANKHD1 HNRNPK EFTUD2 CEP170 PHC3 AHNAK AHCY CBX1 TACC1 WDR62 TTF2 WDR36 DIDO1 FAM193A SCRIB SNRNP200 HDLBP	1.22e-07	934	200	21	33916271
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	PPAN MAP4 CBX3 HNRNPK IQGAP1 EFTUD2 CEP170 MDN1 AHNAK SVIL AHCY CBX1 HERC2 KIFC1 TBC1D15 WDR36 ANXA6 FAM83H TBK1 SCRIB SNRNP200 HDLBP	1.31e-07	1024	200	22	24711643
Pubmed	Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.	ACAN HSPG2 VCAN	1.87e-07	3	200	3	19669783
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ZNF346 GBF1 ACACA MAP1A MAP4 BCAS3 ANKHD1 HNRNPK CEP170 AHNAK CBX1 DHX35 OXSR1 DNMBP MPP1 FAM193A PHF3 HDLBP	2.40e-07	724	200	18	36232890
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ACACA MYO1C SNAP47 HNRNPK EFTUD2 VPS52 MAGED2 AHNAK PDS5A TACC1 WDR36 DSCAM APEH MUC16 KBTBD2 SCRIB SNRNP200 ATP6V0A2	6.66e-07	777	200	18	35844135
Pubmed	E3 ubiquitin ligase HECW2 mediates the proteasomal degradation of HP1 isoforms.	CBX3 HECW2 CBX1	7.46e-07	4	200	3	30208514
Pubmed	Lecticans: organizers of the brain extracellular matrix.	ACAN BCAN VCAN	7.46e-07	4	200	3	10766023
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MAP4 CBX3 MPDZ THSD1 HNRNPK IQGAP1 CEP170 MAGED2 AHNAK AHCY PDS5A TTF2 TBC1D15 ARHGEF12 SCRIB SNRNP200 HDLBP	8.47e-07	708	200	17	39231216
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ACACA CBX3 ANKHD1 PHC3 AHNAK CSTF2T WDR62 TBC1D15 NCOR2 KMT2D FAM193A TLE3 TBK1	1.05e-06	418	200	13	34709266
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	PPAN MYO1C MAP4 ZNF185 CBX3 HNRNPK IQGAP1 EFTUD2 CEP170 MAGED2 AHNAK SVIL AHCY CBX1 KIFC1 WDR36 DIDO1 FAM83H AFAP1 PHF3 SCRIB SNRNP200 HDLBP	1.09e-06	1257	200	23	36526897
Pubmed	Network organization of the human autophagy system.	GBF1 ACACA MAP1A NET1 MAP4 IQGAP1 MAGED2 TECPR2 AGL WDR62 TBC1D15 TBK1 FLCN	1.72e-06	437	200	13	20562859
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	GADD45B CPAMD8 UFSP2 MYO1C MAP1A NET1 IRF3 CEP170 LPIN1 PHC3 MDN1 TECPR2 FKTN CPT1C AHNAK DOP1B MUC20 KLHDC9 TLE3 VCAN PDE4DIP TNXB HDLBP	1.76e-06	1293	200	23	15342556
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	MAGED2 SVIL SHPRH HERC2 DNMBP ABCC10 ATG16L2 WDR36 ATF6B PDE4DIP CDH5 ATP6V0A2	1.84e-06	371	200	12	15747579
Pubmed	The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding.	ACAN BCAN VCAN	1.86e-06	5	200	3	11038354
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	ADAM11 HSPG2 NID2 COL7A1 VCAN TNXB	1.91e-06	64	200	6	22261194
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	ACACA MYO1C SNAP47 CEP170 VPS52 MDN1 AGL PDS5A HERC2 WDR62 TTF2 TBC1D15 SZT2 FAM83H TBK1	2.65e-06	606	200	15	36538041
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	GBF1 BCAS3 DACH1 IRF3 ANKHD1 MDN1 AGL AHCY PDS5A TTF2 CPOX FAAP100 NCOR2 KMT2D TLE3 SCRIB CABIN1 SNRNP200	2.65e-06	857	200	18	25609649
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	GBF1 ACACA MYO1C MAP4 IQGAP1 AHNAK HERC2 FRYL SNRNP200	2.85e-06	202	200	9	33005030
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	MAP4 HNRNPK IQGAP1 AGL PKHD1 DSCAM SCRIB SNRNP200 HDLBP	2.85e-06	202	200	9	24639526
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	MCC CBX3 HNRNPK IQGAP1 ITPR1 EFTUD2 CEP170 AHNAK SVIL AHCY CBX1 PDS5A DHX35 HERC2 WDR62 KIFC1 FAAP100 FAM83H CEP135 SCRIB SNRNP200	3.65e-06	1155	200	21	20360068
Pubmed	Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch).	ACAN HSPG2 VCAN	3.70e-06	6	200	3	9486530
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ACACA MYO1C MAP4 ZNF185 CBX3 ANKHD1 HNRNPK IQGAP1 EFTUD2 MDN1 MAGED2 AHNAK AHCY CBX1 PDS5A HERC2 TTF2 WDR36 FAM83H NCOR2 SCRIB SNRNP200 HDLBP	3.74e-06	1353	200	23	29467282
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	ERCC5 ACACA MYO1C MAP4 CBX3 IQGAP1 MDN1 MAGED2 AHNAK AHCY PDS5A ANXA6	3.89e-06	399	200	12	37536630
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	MAP4 HNRNPK IQGAP1 EFTUD2 MDN1 AHNAK PDS5A DIDO1 PHF3 SNRNP200 HDLBP	3.98e-06	332	200	11	32786267
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	ACACA MYO1C HNRNPK IQGAP1 EFTUD2 MAGED2 AHNAK AHCY ANXA6 COL5A3 KCTD3 SNRNP200 HDLBP	4.47e-06	477	200	13	31300519
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MAP1A CBX3 LMTK3 HNRNPK EFTUD2 CEP170 EHBP1L1 PCDH15 CBX1 PDS5A DHX35 HAX1 CSTF2T ANXA6 DIDO1 AFAP1 VCAN KCTD3 SNRNP200 TNXB	4.95e-06	1082	200	20	38697112
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ZNF346 PPAN NET1 MAP4 MPDZ ANKHD1 IQGAP1 PHC3 MDN1 CBX1 PDS5A HERC2 DNMBP CSTF2T KIFC1 WDR36 ARHGEF12 DIDO1 AFAP1 PHF3 IGHMBP2 KCTD3 ATP6V0A2 HDLBP	6.10e-06	1497	200	24	31527615
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	MYO1C MAP4 CBX3 HNRNPK CEP170 VPS52 MAGED2 AHNAK SVIL APEH VCAN SCRIB HDLBP	7.10e-06	498	200	13	36634849
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	MYO1C ANKHD1 HNRNPK IQGAP1 CEP170 LPIN1 EHBP1L1 MAGED2 AHNAK SVIL DIDO1	8.54e-06	360	200	11	33111431
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DENND4A GBF1 ACACA MYO1C MAP4 CBX3 ANKHD1 HNRNPK IQGAP1 EFTUD2 MDN1 MAGED2 AHCY PDS5A HAX1 KIFC1 TBC1D15 WDR36 ANXA6 CPOX TBK1 SNRNP200 HDLBP	8.67e-06	1425	200	23	30948266
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	PPAN BCAS3 DACH1 LMTK3 ANKHD1 HNRNPK LPIN1 PHF3 PDE4DIP	9.04e-06	233	200	9	37704626
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ACACA NET1 BCAS3 ITPR1 EFTUD2 MDN1 CACNA1G HSPG2 FAM193A PDE4DIP CABIN1	9.23e-06	363	200	11	14691545
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYO1C MAP1A MAP4 BCAS3 ZNF185 YJEFN3 SNAP47 PLEKHG5 HNRNPK IQGAP1 CEP170 HECW2 SVIL HAX1 ARHGEF12 BCAN ADAM22 AFAP1 VCAN PDE4DIP SCRIB SNRNP200 HDLBP	9.28e-06	1431	200	23	37142655
Pubmed	Murine and human cathepsin Z: cDNA-cloning, characterization of the genes and chromosomal localization.	PLTP PTPRT PCK1	1.03e-05	8	200	3	10760573
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	PPAN ACACA CBX3 ITPR1 RPS6KC1 CEP170 MAGED2 DHX35 HERC2 WDR36 PHF3 SCRIB	1.04e-05	440	200	12	34244565
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF346 MAP4 DACH1 CBX3 HNRNPK EFTUD2 CEP170 PHC3 AHNAK CBX1 PDS5A KIFC1 WDR36 DIDO1 NCOR2 PHF3 SNRNP200 HDLBP	1.14e-05	954	200	18	36373674
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	GBF1 ACACA MAP4 CBX3 MPDZ ANKHD1 HNRNPK IQGAP1 EFTUD2 CEP170 MDN1 MAGED2 AGL AHNAK SVIL AHCY PDS5A TLE3 SNRNP200 HDLBP	1.19e-05	1149	200	20	35446349
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	HSPG2 NID2 COL7A1 ANXA6 COL5A3 VCAN TNXB	1.39e-05	135	200	7	28675934
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	GBF1 ACACA MYO1C MAP4 ZNF185 CBX3 IQGAP1 EFTUD2 CEP170 MAGED2 AGL AHNAK AHCY OXSR1 WDR36 ANXA6 APEH FRYL CPOX NCOR2 SCRIB HDLBP	1.44e-05	1367	200	22	32687490
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	ACACA MAP1A BCAS3 CBX3 ANKHD1 CEP170 AGL AHCY HAX1 APEH LARS2 SCRIB HDLBP	1.49e-05	534	200	13	35032548
Pubmed	ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response.	IRF3 IFIT2 TBK1	1.53e-05	9	200	3	19416887
Pubmed	Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.	EME1 CEP170 ZFYVE9 HERC2 WDR62 FHOD3 KMT2D	1.68e-05	139	200	7	25476789
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	MAP4 CEP170 AHNAK KIFC1 KIF26B DIDO1 SCRIB SNRNP200 HDLBP	1.91e-05	256	200	9	33397691
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	UFSP2 ACACA ITPR1 AHNAK HERC2 MUC20 COL7A1 SZT2 MUC16 KMT2D FAM193A PDE4DIP TNXB	2.10e-05	552	200	13	10737800
Pubmed	A novel mouse Chromosome 2 congenic strain with obesity phenotypes.	ACSS1 PLTP LPIN3	2.18e-05	10	200	3	15181537
Pubmed	Caspr2 interacts with type 1 inositol 1,4,5-trisphosphate receptor in the developing cerebellum and regulates Purkinje cell morphology.	MAP1A MAP4 ITPR1	2.18e-05	10	200	3	32675284
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MAP4 DACH1 HNRNPK IQGAP1 CEP170 AHCY PDS5A CSTF2T KIFC1 TTF2 ANXA6 APEH DIDO1 RUNX2 NCOR2 KMT2D TLE3 SNRNP200 HDLBP	2.29e-05	1103	200	19	34189442
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	MYO1C MAP4 IQGAP1 EFTUD2 CEP170 VPS52 MAGED2 PDS5A DHX35 HAX1 TBC1D15 WDR36 SNRNP200	2.44e-05	560	200	13	35241646
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ACACA HNRNPK RPS6KC1 MDN1 HECW2 AGL AHNAK PKHD1 PDS5A DOP1B KIF26B SLC22A16 TBK1 SCRIB SNRNP200	2.63e-05	736	200	15	29676528
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	MYO1C MAP4 MAGED2 PKHD1 SZT2 PHF3 SCRIB DOP1A	2.96e-05	208	200	8	33230847
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GBF1 ACSS1 EFTUD2 CEP170 FAT2 TTBK1 PDS5A CSTF2T WDFY4 CEP135 SNRNP200 DOP1A	3.18e-05	493	200	12	15368895
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	MDN1 TECPR2 HERC2 ARHGEF12 DIDO1 CABIN1	3.19e-05	104	200	6	9205841
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	MAP4 HNRNPK IQGAP1 EFTUD2 AGL AHNAK AHCY PDS5A KIFC1 APEH CPOX SNRNP200	3.25e-05	494	200	12	26831064
Pubmed	The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.	IRF3 TBK1	3.29e-05	2	200	2	17562815
Pubmed	Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction.	IRF3 TBK1	3.29e-05	2	200	2	28848048
Pubmed	Disruption of de novo fatty acid synthesis via acetyl-CoA carboxylase 1 inhibition prevents acute graft-versus-host disease.	ACACA TACC1	3.29e-05	2	200	2	27338930
Pubmed	A novel giant peroxisomal superoxide dismutase motif-containing protein.	MYOC SZT2	3.29e-05	2	200	2	20045724
Pubmed	Identification and characterization of versican/PG-M aggregates in cartilage.	ACAN VCAN	3.29e-05	2	200	2	16648631
Pubmed	Triggering the interferon antiviral response through an IKK-related pathway.	IRF3 TBK1	3.29e-05	2	200	2	12702806
Pubmed	Cleavage of the carboxyl tail from the G3 domain of aggrecan but not versican and identification of the amino acids involved in the degradation.	ACAN VCAN	3.29e-05	2	200	2	11932252
Pubmed	Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation.	IRF3 TBK1	3.29e-05	2	200	2	14703513
Pubmed	IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts.	IRF3 TBK1	3.29e-05	2	200	2	14679297
Pubmed	Regulation of an inducible promoter by an HP1beta-HP1gamma switch.	CBX3 CBX1	3.29e-05	2	200	2	18239689
Pubmed	TLE3, transducing-like enhancer of split 3, suppresses osteoblast differentiation of bone marrow stromal cells.	RUNX2 TLE3	3.29e-05	2	200	2	23880346
Pubmed	Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch.	IRF3 TBK1	3.29e-05	2	200	2	17526488
Pubmed	Functional domain analysis of human HP1 isoforms in Drosophila.	CBX3 CBX1	3.29e-05	2	200	2	17575412
Pubmed	Contribution of Mutations in Known Mendelian Glaucoma Genes to Advanced Early-Onset Primary Open-Angle Glaucoma.	WDR36 TBK1	3.29e-05	2	200	2	28282485
Pubmed	Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet.	GADD45B AHCY	3.29e-05	2	200	2	20938992
Pubmed	Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway.	IRF3 TBK1	3.29e-05	2	200	2	16537515
Pubmed	[Association of single nucleotide polymorphisms of CSPG2 and HSPG2 genes with intracranial aneurysm in ethnic Han Chinese population].	HSPG2 VCAN	3.29e-05	2	200	2	23568740
Pubmed	Morphogenesis in Aspergillus nidulans requires Dopey (DopA), a member of a novel family of leucine zipper-like proteins conserved from yeast to humans.	DOP1B DOP1A	3.29e-05	2	200	2	10931277
Pubmed	Differential proteoglycan expression in two spinal cord regions after dorsal root injury.	BCAN VCAN	3.29e-05	2	200	2	19683574
Pubmed	Haploinsufficiency of Lipin3 leads to hypertriglyceridemia and obesity by disrupting the expression and nucleocytoplasmic localization of Lipin1.	LPIN1 LPIN3	3.29e-05	2	200	2	37776435
Pubmed	Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B.	ATF6B TNXB	3.29e-05	2	200	2	7686164
Pubmed	SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.	IRF3 TBK1	3.29e-05	2	200	2	33637958
Pubmed	A sequence motif found in a Drosophila heterochromatin protein is conserved in animals and plants.	CBX3 CBX1	3.29e-05	2	200	2	1708124
Pubmed	The phosphatidic acid-binding, polybasic domain is responsible for the differences in the phosphoregulation of lipins 1 and 3.	LPIN1 LPIN3	3.29e-05	2	200	2	28982975
Pubmed	Mouse Dach, a homologue of Drosophila dachshund, is expressed in the developing retina, brain and limbs.	DACH1 PCDH8	3.29e-05	2	200	2	10502109
Pubmed	Alternate promoters and alternate splicing of human tenascin-X, a gene with 5' and 3' ends buried in other genes.	ATF6B TNXB	3.29e-05	2	200	2	8923003
Pubmed	The effect of LILRB1 but not LILRA3 gene polymorphism in immunopathology of ankylosing spondylitis-A parallel to KIR genes.	LILRB1 LILRA3	3.29e-05	2	200	2	30892832
Pubmed	Deletion of Runx2 in Articular Chondrocytes Decelerates the Progression of DMM-Induced Osteoarthritis in Adult Mice.	ACAN RUNX2	3.29e-05	2	200	2	28539595
Pubmed	The intracranial aneurysm susceptibility genes HSPG2 and CSPG2 are not associated with abdominal aortic aneurysm.	HSPG2 VCAN	3.29e-05	2	200	2	20053631
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	BCAS3 IRF3 PALMD CEP170 LPIN1 VPS52 MAGED2 DHX35 HAX1 ATG16L2 TTF2 TBC1D15 TRAK1 LPIN3 BTBD7 TBK1 KCTD3 BLOC1S3	3.47e-05	1038	200	18	26673895
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	GBF1 MAP4 HNRNPK CEP170 MAGED2 HECW2 HERC2 PCDHGA3 MUC16 PTPRT DOP1A	3.53e-05	420	200	11	28065597
Pubmed	The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.	ERCC5 GBF1 ANKHD1 WDR62 KMT2D SCRIB	3.55e-05	106	200	6	31024071
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ZNF346 PPAN MAP4 HNRNPK IQGAP1 CEP170 MDN1 MAGED2 HERC2 KIFC1 WDR36 DIDO1 PHF3 IGHMBP2 SNRNP200	3.73e-05	759	200	15	35915203
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	PPAN ACACA MYO1C MAP4 CBX3 HNRNPK IQGAP1 EFTUD2 SVIL AHCY DHX35 OXSR1 APEH RUNX2 FAM83H NCOR2 PHF3 IGHMBP2 TBK1 HDLBP	3.78e-05	1247	200	20	27684187
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	UFSP2 ACACA MYO1C CBX3 IQGAP1 ITPR1 AHNAK SVIL DPY19L1 FAM83H PDE4DIP HDLBP	3.86e-05	503	200	12	36217030
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	DENND4A GBF1 SNAP47 ITPR1 RPS6KC1 ZFYVE9 TACC1 DOP1B TBC1D15 ATF6B ADAM22 FLCN	3.94e-05	504	200	12	34432599
Pubmed	Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT).	PTPRQ PTPRT CDH5	3.97e-05	12	200	3	16973135
Pubmed	TRAF3IP3 mediates the recruitment of TRAF3 to MAVS for antiviral innate immunity.	IRF3 IFIT2 TBK1	3.97e-05	12	200	3	31390091
Interaction	GSK3B interactions	DENND4A ACACA MYO1C MAP1A MAP4 MPDZ HNRNPK IQGAP1 EFTUD2 MAGED2 HECW2 HAX1 HERC2 WDR62 MPP1 KIF26B PLEKHA4 ARHGEF12 APEH TRAK1 AFAP1 FAM193A TLE3 TBK1 SCRIB	1.34e-06	868	197	25	int:GSK3B
Interaction	TOP3B interactions	GADD45B GBF1 ACACA MYO1C BCAS3 ANKLE1 ANKHD1 PLEKHG5 IQGAP1 EHBP1L1 MDN1 AHNAK SVIL HERC2 DNMBP ABCC10 HSPG2 ARHGEF19 WDR36 SZT2 PLEKHA4 APEH FRYL LARS2 FAAP100 FAM83H TRAK1 LPIN3 NCOR2 KMT2D BTBD7 FLCN CABIN1 HDLBP	2.19e-06	1470	197	34	int:TOP3B
Interaction	YWHAH interactions	DENND4A GBF1 NET1 BCAS3 MPDZ PLEKHG5 HNRNPK IQGAP1 EFTUD2 CEP170 AHNAK SVIL DNMBP WDR62 DOP1B KIF26B PLEKHA4 FRYL FAM83H TRAK1 LPIN3 PHF3 TBK1 CEP135 FLCN SCRIB FRMD5 DOP1A	3.40e-06	1102	197	28	int:YWHAH
Interaction	YWHAG interactions	DENND4A GBF1 NET1 BCAS3 MCC MPDZ PLEKHG5 IQGAP1 EFTUD2 CEP170 LPIN1 TTBK1 MDN1 SVIL SHPRH DNMBP LNX1 WDR62 KIF26B PLEKHA4 FRYL PPEF2 FAM83H TRAK1 LPIN3 PHF3 SCRIB SNRNP200 FRMD5 DOP1A	4.44e-06	1248	197	30	int:YWHAG
Interaction	YWHAQ interactions	DENND4A GBF1 ACACA MAP4 PLEKHG5 HNRNPK IQGAP1 EFTUD2 CEP170 SVIL AHCY HAX1 DNMBP LNX1 WDR62 KIF26B PLEKHA4 FRYL LARS2 FAM83H TRAK1 LPIN3 SCRIB CABIN1 PCK1 FRMD5 DOP1A	1.30e-05	1118	197	27	int:YWHAQ
Interaction	BAG5 interactions	MYO1C MAP1A MAP4 BCAS3 ANKHD1 EFTUD2 AHNAK HAX1 WDR62 NCOR2 SNRNP200 FRMD5 HDLBP	3.28e-05	341	197	13	int:BAG5
Interaction	WEE2-AS1 interactions	GBF1 MYO1C MAP1A MAGED2 AHNAK HAX1 DIDO1 FAM83H KCTD3	3.32e-05	163	197	9	int:WEE2-AS1
Interaction	KCNA3 interactions	MYO1C MAP4 CBX3 MPDZ THSD1 HNRNPK IQGAP1 CEP170 MAGED2 AHNAK AHCY PKHD1 PDS5A TTF2 TBC1D15 SZT2 ARHGEF12 PHF3 SCRIB SNRNP200 DOP1A HDLBP	4.54e-05	871	197	22	int:KCNA3
Interaction	SNW1 interactions	CBX3 HNRNPK IQGAP1 EFTUD2 MDP1 MDN1 ZSCAN1 MAGED2 HECW2 AHNAK AHCY DHX35 OXSR1 LNX1 PLEKHA4 RUNX2 TRAK1 NCOR2 SNRNP200 HDLBP	4.62e-05	747	197	20	int:SNW1
Interaction	GSK3A interactions	DENND4A ACACA MAP1A MPDZ HNRNPK MDN1 MAGED2 WDR62 KIF26B PLEKHA4 ARHGEF12 TRAK1 AFAP1 FAM193A SCRIB	5.46e-05	464	197	15	int:GSK3A
Interaction	SPAST interactions	MAP1A BCAS3 SNAP47 CEP170 HECW2 SVIL PLEKHA4 HDLBP	5.85e-05	136	197	8	int:SPAST
Interaction	YAP1 interactions	GBF1 ACACA MYO1C MAP4 DACH1 DDN MPDZ IRF3 HNRNPK IQGAP1 CEP170 HECW2 AHNAK AHCY CSTF2T TTF2 TBC1D15 DIDO1 RUNX2 KMT2D PHF3 TBK1 SCRIB SNRNP200 HDLBP	6.97e-05	1095	197	25	int:YAP1
Interaction	WDR62 interactions	GOLGA6L2 MAP4 CEP170 HAX1 HERC2 WDR62 PLEKHA4	7.32e-05	104	197	7	int:WDR62
Interaction	CCDC71 interactions	ACACA MAP1A CBX3 CBX1 NID2 FRYL	7.39e-05	72	197	6	int:CCDC71
Interaction	CCDC8 interactions	MAP4 IQGAP1 EFTUD2 CEP170 MDN1 AHNAK SVIL NHLH2 HERC2 KIFC1 TBC1D15 ANXA6 FAM83H TBK1 SCRIB CDH5 SNRNP200 HDLBP	8.25e-05	656	197	18	int:CCDC8
Interaction	PCDHA12 interactions	UFSP2 PCDHA7 PPOX IL1RAP FRMD5	8.40e-05	46	197	5	int:PCDHA12
Interaction	BRCA1 interactions	EME1 ERCC5 GBF1 ACACA MAP4 CBX3 HNRNPK IQGAP1 ITPR1 EFTUD2 CEP170 MDN1 AGL AHNAK AHCY CBX1 PDS5A HERC2 KIFC1 APEH CPOX FAAP100 FAM83H AFAP1 CABIN1 SNRNP200 HDLBP	8.80e-05	1249	197	27	int:BRCA1
Cytoband	19p13.11	CPAMD8 ANKLE1 YJEFN3 NWD1	3.01e-04	73	200	4	19p13.11
Cytoband	6q15	MDN1 CFAP206 DOP1A	3.35e-04	31	200	3	6q15
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN BCAN VCAN	1.41e-06	4	129	3	574
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	NET1 DNMBP ARHGEF19 ARHGEF12 ARHGEF35	1.08e-04	66	129	5	722
GeneFamily	PDZ domain containing	MPDZ AHNAK FRMPD2B LNX1 MPP1 ARHGEF12 SCRIB	1.10e-04	152	129	7	1220
GeneFamily	Lipins	LPIN1 LPIN3	1.51e-04	3	129	2	1043
GeneFamily	Fibronectin type III domain containing	FNDC1 PTPRQ ROBO3 COL7A1 DSCAM PTPRT TNXB	1.51e-04	160	129	7	555
GeneFamily	Cadherin related	FAT2 PCDH15 DCHS1	2.24e-04	17	129	3	24
GeneFamily	Chromobox family	CBX3 CBX1	1.38e-03	8	129	2	976
GeneFamily	Zinc fingers AN1-type\|UPF1 like RNA helicases	ZFAND4 IGHMBP2	1.38e-03	8	129	2	63
GeneFamily	Immunoglobulin like domain containing	HMCN2 ROBO3 HSPG2 DSCAM PTPRT IL1RAP	2.63e-03	193	129	6	594
GeneFamily	WD repeat domain containing	BCAS3 WDR62 ATG16L2 NWD1 WDR36 WDFY4 TLE3	2.76e-03	262	129	7	362
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN BCAN VCAN	3.10e-03	41	129	3	1298
GeneFamily	Non-clustered protocadherins	PCDH12 PCDH8	3.18e-03	12	129	2	21
GeneFamily	PHD finger proteins	SHPRH DIDO1 KMT2D PHF3	3.94e-03	90	129	4	88
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HMCN2 ROBO3 HSPG2 DSCAM WFIKKN2	5.97e-03	161	129	5	593
ToppCell	facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 DDN ADAM11 ITPR1 AHNAK ROBO3 PLTP IL17RB RUNX2 CDH5	9.52e-09	180	200	10	bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCell	facs-Marrow-B-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 DDN ADAM11 ITPR1 AHNAK ROBO3 PLTP IL17RB RUNX2 CDH5	9.52e-09	180	200	10	82965ed1b72a1873c24dd4553d39681596057316
ToppCell	ASK440-Endothelial-Endothelium\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	DACH1 MCC PALMD THSD1 PCDH12 HECW2 HSPG2 LILRA3 DCHS1 CDH5	2.04e-08	195	200	10	304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 DDN ADAM11 ITPR1 AHNAK PLTP IL17RB RUNX2 CDH5	1.31e-07	180	200	9	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM11 GPR179 ITPR1 PCDH15 CACNA1G MUC20 DSCAM PTPRT VCAN	1.31e-07	180	200	9	8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	GBF1 ANKRD36C SHPRH DOP1B MUC20 TTF2 WDR36 FRYL RUNX2	1.73e-07	186	200	9	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A MYO1C IQGAP1 ITPR1 AHNAK DNMBP IFT57 WDFY4 TRAK1	2.59e-07	195	200	9	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A MYO1C IQGAP1 ITPR1 AHNAK DNMBP IFT57 WDFY4 TRAK1	2.59e-07	195	200	9	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	DACH1 MPDZ THSD1 PCDH12 MAGED2 AHNAK PLTP NID2 CDH5	3.07e-07	199	200	9	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	FNDC1 CFAP54 ZSCAN1 HMCN2 ACAN COL7A1 KIF26B VCAN	8.00e-07	164	200	8	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 DDN ADAM11 ROBO3 PLTP RUNX2 AGMO CDH5	1.10e-06	171	200	8	4e856441063e9825b6f87a1d3dd19c77dae4662c
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 DDN ADAM11 ROBO3 PLTP IL17RB RUNX2 CDH5	1.14e-06	172	200	8	30916a902c151907745756d14327e24adc34afef
ToppCell	facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ITPR1 AHNAK PLTP IL17RB RUNX2 CDH5	1.36e-06	176	200	8	74f851a398c7562dd713bc0d8d488c0037243112
ToppCell	facs-Marrow-T_cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ITPR1 AHNAK PLTP IL17RB RUNX2 CDH5	1.36e-06	176	200	8	31b5459a978d5cdde0af03a77401e0464d8c95ba
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ROBO3 PLTP DPY19L1 IFT57 RUNX2 CDH5	1.48e-06	178	200	8	742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM11 GPR179 PCDH15 CACNA1G MUC20 DSCAM PTPRT VCAN	1.54e-06	179	200	8	7c8a2fa1326c73dc9e774df645b572864fd97133
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ITPR1 AHNAK ROBO3 PLTP RUNX2 CDH5	1.61e-06	180	200	8	df60970520fba2ac0639faa54096766d07418ca4
ToppCell	facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ITPR1 AHNAK PLTP IL17RB RUNX2 CDH5	1.68e-06	181	200	8	782716b8b1d447d2bbe09a693fa5ed7ebeac0efb
ToppCell	facs-Marrow-B-cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ITPR1 AHNAK PLTP IL17RB RUNX2 CDH5	1.68e-06	181	200	8	e2481291c236105774c53883e6f20da11941df9b
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	GBF1 SHPRH DOP1B MUC20 TTF2 WDR36 FRYL KMT2D	1.98e-06	185	200	8	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2\|TCGA-Kidney / Sample_Type by Project: Shred V9	THSD1 PCDH12 FNDC1 HECW2 ACAN NID2 COL5A3 DCHS1	2.06e-06	186	200	8	1e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCell	E17.5-Endothelial-unknown_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DACH1 PALMD THSD1 PCDH12 HECW2 PLTP NID2 CDH5	2.14e-06	187	200	8	da885c26ccc5189b1ff1f607552e00a5c0e49e7e
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	DACH1 MCC PALMD PCDH12 HECW2 CPT1C PCDH15 CDH5	2.14e-06	187	200	8	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	E17.5-Endothelial-unknown_endothelial_cell-endothelial_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DACH1 PALMD THSD1 PCDH12 HECW2 PLTP NID2 CDH5	2.14e-06	187	200	8	1f358d02ec69d44dea2e2831af9473ed05dcf8cc
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYCP2L DACH1 PALMD THSD1 HECW2 PCDH15 FRYL CDH5	2.23e-06	188	200	8	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC PALMD THSD1 PCDH12 HECW2 IFIT2 CDH5	2.23e-06	188	200	8	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DACH1 MCC PALMD HECW2 TACC1 LNX1 HSPG2 CDH5	2.32e-06	189	200	8	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC PALMD THSD1 PCDH12 HECW2 IFIT2 CDH5	2.41e-06	190	200	8	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC THSD1 PCDH12 HECW2 ARHGEF12 IFIT2 CDH5	2.60e-06	192	200	8	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PALMD THSD1 PCDH12 HECW2 HSPG2 NID2 PIK3R6 CDH5	2.60e-06	192	200	8	1f35efb0765e05f7f9c881849953bef3965be25a
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC PALMD THSD1 PCDH12 HECW2 PIK3R6 CDH5	2.71e-06	193	200	8	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALMD PCDH12 HECW2 TACC1 HSPG2 AFAP1 CDH5 TNXB	2.71e-06	193	200	8	1f978e102a029a6beb10913052cd0a20c7253e8e
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC PALMD THSD1 PCDH12 HECW2 ARHGEF12 CDH5	2.71e-06	193	200	8	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC PALMD THSD1 PCDH12 HECW2 ARHGEF12 CDH5	2.71e-06	193	200	8	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC PALMD THSD1 PCDH12 HECW2 ARHGEF12 CDH5	2.81e-06	194	200	8	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC PALMD THSD1 PCDH12 HECW2 ARHGEF12 CDH5	2.81e-06	194	200	8	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	Endothelial-A-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	DACH1 PALMD THSD1 PCDH12 HSPG2 DCHS1 CDH5 TNXB	2.81e-06	194	200	8	e656ac5539e59e321b46706cb8cc423b2c3358a0
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	GABRE MPDZ PALMD PCDH12 PLTP HSPG2 DCHS1 CDH5	3.15e-06	197	200	8	4e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-tip_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MPDZ PALMD THSD1 PCDH12 HECW2 HSPG2 DCHS1 CDH5	3.52e-06	200	200	8	77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP4 DACH1 PALMD THSD1 PCDH12 AHNAK ARHGEF12 CDH5	3.52e-06	200	200	8	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GABRE MPDZ PALMD PCDH12 PLTP HSPG2 DCHS1 CDH5	3.52e-06	200	200	8	ae429f2de652cc1976e63644781197e9ce0e70c8
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PCDH15 DSCAM KIF26B BCAN PTPRT AFAP1 VCAN IL1RAP	3.52e-06	200	200	8	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP4 DACH1 PALMD THSD1 PCDH12 AHNAK ARHGEF12 CDH5	3.52e-06	200	200	8	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PCDH15 DSCAM KIF26B BCAN PTPRT AFAP1 VCAN IL1RAP	3.52e-06	200	200	8	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PCDH15 DSCAM KIF26B BCAN PTPRT AFAP1 VCAN IL1RAP	3.52e-06	200	200	8	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PCDH15 DSCAM KIF26B BCAN PTPRT AFAP1 VCAN IL1RAP	3.52e-06	200	200	8	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP4 DACH1 PALMD THSD1 PCDH12 AHNAK ARHGEF12 CDH5	3.52e-06	200	200	8	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PCDH15 DSCAM KIF26B BCAN PTPRT AFAP1 VCAN IL1RAP	3.52e-06	200	200	8	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PCDH15 DSCAM KIF26B BCAN PTPRT AFAP1 VCAN IL1RAP	3.52e-06	200	200	8	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD31 MAP1A ITPR1 FNDC1 COL5A3 FAM83H TNXB	7.16e-06	157	200	7	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	GADD45B MCC HECW2 CPT1C TACC1 SLC22A16 VCAN	7.47e-06	158	200	7	de65af8d3b8514b17978155f31975e2347b75251
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACA MCC AGL ROBO3 COL7A1 COL5A3 PIK3R6	1.07e-05	167	200	7	528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACA MCC AGL ROBO3 COL7A1 COL5A3 PIK3R6	1.07e-05	167	200	7	a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCell	droplet-Marrow-BM-1m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERCC5 BFSP1 AHNAK NECTIN4 WDR62 WDR36 PPEF2	1.11e-05	168	200	7	2e88d9cb7c80a4656fab290db8b45a5a0599d769
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GADD45B ABCA12 PCDH15 PKHD1 DSCAM LARS2 PTPRT	1.16e-05	169	200	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ITPR1 AHNAK ROBO3 PLTP RUNX2 CDH5	1.25e-05	171	200	7	6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794
ToppCell	facs-Marrow-T-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ITPR1 AHNAK ROBO3 PLTP RUNX2 CDH5	1.25e-05	171	200	7	e02b5831768dbb1b68998b672e55c9680ab0cc86
ToppCell	facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 AHNAK ROBO3 PLTP RUNX2 CDH5	1.35e-05	173	200	7	ca3d2a9562734f76127e3e7d54c10b63e95141bb
ToppCell	facs-Marrow-T-cells-24m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 AHNAK ROBO3 PLTP RUNX2 CDH5	1.35e-05	173	200	7	19a9e10885173d7712996be8660a3a5a7a9aa39f
ToppCell	CV-Mild-7\|Mild / Virus stimulation, Condition and Cluster	PPAN IQGAP1 PLTP DPY19L1 RUNX2 CABIN1 DOP1A	1.35e-05	173	200	7	c9bbca9313a0fdf146c8c995624b94b937e818d8
ToppCell	droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 DDN ADAM11 ROBO3 PLTP RUNX2 CDH5	1.45e-05	175	200	7	21bc0e59a9509d38751ce6aad2325f341bc70eff
ToppCell	droplet-Marrow-nan-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ITPR1 ROBO3 PLTP RUNX2 CDH5	1.68e-05	179	200	7	dcaf2191134a586d50ebaf67dcf5b815b54a722b
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ROBO3 PLTP RUNX2 KLHDC9 CDH5	1.68e-05	179	200	7	d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159
ToppCell	droplet-Fat-Gat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF346 PALMD PLEKHG5 ZFYVE9 PIK3R6 DCHS1 CDH5	1.68e-05	179	200	7	08cf9986804a6417a9afb19b50c69a3554f71ec6
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 ADAM11 ITPR1 ROBO3 PLTP RUNX2 CDH5	1.68e-05	179	200	7	87a69f9f83b8f0c028a4874acb238f2e079bf51f
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CPAMD8 DACH1 MCC PALMD TACC1 FRYL CDH5	1.68e-05	179	200	7	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 DDN ADAM11 ROBO3 PLTP RUNX2 CDH5	1.74e-05	180	200	7	64f01494a4052186773720e10b4e7c724ff94547
ToppCell	Endothelial-A-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	DACH1 PALMD PCDH12 HECW2 DCHS1 CDH5 TNXB	1.74e-05	180	200	7	4c3376169770ee9f9283daae44c17f35e46bfd19
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC THSD1 PCDH12 HECW2 IFIT2 CDH5	1.94e-05	183	200	7	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MCC PALMD FNDC1 HMCN2 SVIL KIF26B RUNX2	2.01e-05	184	200	7	7d41784eac0935e77d6bc701f20c693adf998730
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	SYCP2L DACH1 PALMD PCDH12 HECW2 DCHS1 CDH5	2.08e-05	185	200	7	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	356C-Endothelial_cells-Endothelial-E-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SYCP2L PALMD THSD1 PCDH12 HMCN2 HSPG2 CDH5	2.15e-05	186	200	7	2e024097ee361eeb1d855a4edb8ac8cdad35da06
ToppCell	356C-Endothelial_cells-Endothelial-E\|356C / Donor, Lineage, Cell class and subclass (all cells)	SYCP2L PALMD THSD1 PCDH12 HMCN2 HSPG2 CDH5	2.15e-05	186	200	7	c3449e54454009973818fc1101933c6f0168258c
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	DACH1 PALMD PCDH12 BFSP1 HMCN2 HSPG2 CDH5	2.15e-05	186	200	7	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PALMD THSD1 PCDH12 HECW2 HSPG2 PIK3R6 CDH5	2.23e-05	187	200	7	0ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALMD PCDH12 HECW2 TACC1 HSPG2 CDH5 TNXB	2.23e-05	187	200	7	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC THSD1 PCDH12 HECW2 IFIT2 CDH5	2.23e-05	187	200	7	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	MYOC FNDC1 HMCN2 LNX1 COL5A3 VCAN TNXB	2.30e-05	188	200	7	409a7b69d02e87084ca955e3fe6c77230dee8861
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 PALMD THSD1 PCDH12 HECW2 PIK3R6 CDH5	2.38e-05	189	200	7	e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A MYO1C IQGAP1 ITPR1 IFT57 WDFY4 TRAK1	2.38e-05	189	200	7	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	GBF1 ANKRD36C IQGAP1 DOP1B WDR36 FRYL RUNX2	2.55e-05	191	200	7	9454f642c3621370fa23640b631301346b300950
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 PALMD THSD1 FAT2 AHNAK CAMTA1 BNIPL	2.55e-05	191	200	7	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOC FNDC1 MAGED2 NID2 COL5A3 VCAN TNXB	2.64e-05	192	200	7	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCC THSD1 HECW2 PLTP ARHGEF12 LARS2 CDH5	2.64e-05	192	200	7	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	facs-Kidney-nan-18m-Endothelial-fenestrated_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCC PALMD PCDH12 PLTP HSPG2 DCHS1 CDH5	2.64e-05	192	200	7	777e386a17bba9ec450bb9d64d8a9ab98d9a63ff
ToppCell	facs-Kidney-nan-18m-Endothelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCC PALMD PCDH12 PLTP HSPG2 DCHS1 CDH5	2.64e-05	192	200	7	60a2409546525a40a5658e0f9d6a50c37f28bb96
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ITPR1 TACC1 NID2 COL5A3 AFAP1 VCAN TNXB	2.64e-05	192	200	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DACH1 PALMD THSD1 PCDH12 HECW2 IFIT2 CDH5	2.64e-05	192	200	7	6c089bde63dd5f16a07c5929fb49df600f0b21ab
ToppCell	facs-Kidney-nan-18m-Endothelial-Pecam____fenestrated_capillary_endothelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCC PALMD PCDH12 PLTP HSPG2 DCHS1 CDH5	2.64e-05	192	200	7	0f9db6091b373334b9beabe0e5782bf2bc54690b
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 HECW2 PLTP HSPG2 NID2 PIK3R6 CDH5	2.73e-05	193	200	7	5d42979d811ee13a07dee08a3743a90776017cb4
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 HECW2 PLTP HSPG2 NID2 PIK3R6 CDH5	2.73e-05	193	200	7	97c0730aad9135ac681250b3871cc094a28f80a7
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 MCC THSD1 PCDH12 HECW2 ARHGEF12 CDH5	2.73e-05	193	200	7	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 HECW2 PLTP HSPG2 NID2 PIK3R6 CDH5	2.73e-05	193	200	7	95e64b9580d30c28702639a043a8b72ce1cadeb6
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 PALMD THSD1 PCDH12 HECW2 PIK3R6 CDH5	2.73e-05	193	200	7	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NET1 MYOC LPIN1 SVIL LNX1 WFIKKN2 FRMD5	2.73e-05	193	200	7	cfab88935abe0a15632c5eec8ff00a857ec9b3ed
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MCC PALMD THSD1 HECW2 KIF26B ARHGEF12 CDH5	2.73e-05	193	200	7	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCC THSD1 HECW2 PLTP ARHGEF12 LARS2 CDH5	2.82e-05	194	200	7	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A MYO1C IQGAP1 AHNAK IFT57 WDFY4 TRAK1	2.82e-05	194	200	7	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NET1 PALMD HECW2 HSPG2 NID2 ARHGEF12 CDH5	2.82e-05	194	200	7	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|World / Lineage and Cell class	MYOC FNDC1 HMCN2 MAGED2 AHNAK HSPG2 TNXB	2.82e-05	194	200	7	c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; HL60; HG-U133A	GADD45B DENND4A MYO1C MAP1A NET1 TACC1 SZT2 DIDO1 BCAN CPOX IFIT2 CABIN1	1.67e-07	198	197	12	1428_DN
Drug	0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A	MAP4 THSD1 ZFYVE9 SVIL ROBO3 COL7A1 DSCAM TRAK1 FLCN HDLBP	5.61e-06	187	197	10	6902_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	DACH1 EHBP1L1 ROBO3 WDR62 AMH SZT2 ADAM22 NCOR2 FLCN CABIN1	7.76e-06	194	197	10	4763_DN
Drug	Methocarbamol [532-03-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	MAP4 BCAS3 MPDZ COL7A1 IFIT2 AFAP1 PHF3 VCAN PDE4DIP CABIN1	7.76e-06	194	197	10	2111_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	MAP4 SLC30A3 PHC3 EHBP1L1 ROBO3 PLTP TRAK1 BTBD7 IGHMBP2 CABIN1	8.11e-06	195	197	10	2290_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A	GADD45B MAP4 MCC ZFYVE9 SVIL PLTP CSTF2T COL7A1 SZT2 PHF3	8.49e-06	196	197	10	2158_DN
Drug	Acetaminophen [103-90-2]; Up 200; 26.4uM; PC3; HT_HG-U133A	TECPR2 ACAN AHNAK CACNA1G ARHGEF12 ADAM22 BTBD7 IGHMBP2 VCAN PDE4DIP	8.87e-06	197	197	10	6284_UP
Drug	Austricine [10180-88-8]; Down 200; 14.2uM; HL60; HT_HG-U133A	ZNF185 MCC MAGED2 AHNAK DNMBP DOP1B COL7A1 BTBD7 IGHMBP2 PDE4DIP	1.01e-05	200	197	10	2157_DN
Drug	elenolic acid	AGL AMH PPOX	3.46e-05	8	197	3	CID000169607
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	MAP4 BBS9 IQGAP1 LPIN1 SZT2 IFIT2 PHF3 BTBD7 PDE4DIP	3.98e-05	188	197	9	4545_DN
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A	PDS5A DNMBP SZT2 ARHGEF12 DIDO1 PDE4DIP FLCN CABIN1 IL1RAP	4.32e-05	190	197	9	7070_UP
Drug	Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; HL60; HT_HG-U133A	GADD45B MYO1C MAP4 DACH1 DDN BTBD7 CABIN1 IL1RAP HDLBP	4.69e-05	192	197	9	2378_DN
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A	MAP4 MCC AHNAK CACNA1G AMH COL7A1 SZT2 NCOR2 IGHMBP2	4.69e-05	192	197	9	3087_UP
Drug	Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A	MAP4 MPDZ PHC3 ZFYVE9 DSCAM ARHGEF12 FAAP100 FLCN DOP1A	4.88e-05	193	197	9	3242_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A	BBS9 ITPR1 CSTF2T PHF3 BTBD7 IGHMBP2 CABIN1 IL1RAP HDLBP	5.08e-05	194	197	9	2824_DN
Drug	Estrone [53-16-7]; Up 200; 14.8uM; HL60; HT_HG-U133A	MAP4 BBS9 ZFYVE9 TECPR2 DHX35 DSCAM FAAP100 IGHMBP2 PDE4DIP	5.08e-05	194	197	9	3071_UP
Drug	Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A	GADD45B BBS9 ITPR1 CSTF2T ARHGEF12 TRAK1 PHF3 VCAN IL1RAP	5.08e-05	194	197	9	4602_DN
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A	BBS9 BFSP1 CSTF2T AMH COL7A1 TRAK1 AFAP1 PHF3 PDE4DIP	5.50e-05	196	197	9	3844_DN
Drug	Trimethadione [127-48-0]; Down 200; 28uM; MCF7; HT_HG-U133A	MYO1C MAP4 PHC3 ROBO3 CSTF2T WDR62 ADAM22 TRAK1 IL1RAP	5.50e-05	196	197	9	4165_DN
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; HL60; HT_HG-U133A	BCAS3 MYOC ZNF185 DDN PCDH12 BBS9 ZFYVE9 ROBO3 COL7A1	5.72e-05	197	197	9	3085_UP
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MYOC SLC30A3 ZFYVE9 HSPG2 SZT2 ADAM22 NCOR2 PCDH8 PCK1	5.72e-05	197	197	9	4134_UP
Drug	(+,-)-Synephrine [94-07-5]; Up 200; 24uM; PC3; HT_HG-U133A	BCAS3 MCC DDN ZFYVE9 PDS5A CACNA1G COL7A1 TRAK1 VCAN	5.72e-05	197	197	9	7150_UP
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	THSD1 BBS9 TECPR2 DOP1B COL7A1 PDE4DIP CEP135 FLCN CABIN1	5.72e-05	197	197	9	3708_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	GADD45B MAP1A MAP4 PHC3 EHBP1L1 DHX35 DSCAM NCOR2 PHF3	5.72e-05	197	197	9	7360_UP
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MAP4 ITPR1 PHC3 ZFYVE9 SVIL TACC1 COL7A1 BTBD7 IGHMBP2	5.72e-05	197	197	9	3308_DN
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A	MAP4 ITPR1 SVIL PDS5A DIDO1 PHF3 BTBD7 VCAN PDE4DIP	5.72e-05	197	197	9	2082_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; PC3; HT_HG-U133A	PCDH12 CSTF2T WDR62 AMH DSCAM IGHMBP2 CEP135 CABIN1 PCK1	5.95e-05	198	197	9	2107_UP
Drug	Oxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A	MAP4 DACH1 THSD1 TECPR2 WDR62 SZT2 PHF3 PDE4DIP CABIN1	5.95e-05	198	197	9	7344_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	THSD1 BBS9 PHC3 EHBP1L1 ZFYVE9 WDR62 HSPG2 ADAM22 CABIN1	5.95e-05	198	197	9	2251_DN
Drug	estradiol, USP; Up 200; 0.01uM; HL60; HG-U133A	UFSP2 NET1 IQGAP1 ITPR1 AHNAK BCAN CPOX PHF3 VCAN	5.95e-05	198	197	9	782_UP
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	DENND4A BBS9 ITPR1 LPIN1 PHC3 SVIL TACC1 AFAP1 BTBD7	6.19e-05	199	197	9	2319_DN
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A	BBS9 BFSP1 COL7A1 DSCAM ARHGEF12 LARS2 ADAM22 TRAK1 IGHMBP2	6.19e-05	199	197	9	3879_DN
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; HL60; HG-U133A	DENND4A MYO1C MAP4 MYOC ZNF185 ITPR1 TACC1 IGHMBP2 KCTD3	6.19e-05	199	197	9	1439_UP
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	DENND4A BBS9 TECPR2 DHX35 ARHGEF12 PHF3 VCAN IL1RAP HDLBP	6.43e-05	200	197	9	5831_DN
Drug	AC1L1F75	ACACA MCC PKHD1 DSCAM	1.09e-04	29	197	4	CID000003112
Drug	2,2'-dipyridylamine	ACACA DACH1 TNXB	1.33e-04	12	197	3	CID000014547
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	GADD45B MAP1A THSD1 LPIN1 MPP1 PDE4DIP IL1RAP DOP1A	1.36e-04	173	197	8	7077_UP
Drug	poly(3-hydroxybutyrate-co-3-hydroxyvalerate	ACAN HSPG2 RUNX2	1.71e-04	13	197	3	CID000107801
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	MAP4 THSD1 SLC30A3 ITPR1 LPIN1 EHBP1L1 TACC1 AFAP1	1.86e-04	181	197	8	7453_UP
Drug	mono-(2-ethylhexyl)phthalate	ABCA12 ZNF185 DACH1 HECW2 PLIN5 AGL AHCY PKHD1 ABCC10 AMH DPY19L1 RUNX2 ADAM22 TNXB PCK1 FRMD5	2.06e-04	658	197	16	ctd:C016599
Drug	scriptaid; Up 200; 10uM; PC3; HT_HG-U133A	GADD45B THSD1 IQGAP1 ITPR1 LPIN1 PHF3 PDE4DIP DOP1A	2.08e-04	184	197	8	6919_UP
Drug	dimolybdenum	ACACA APEH	2.22e-04	3	197	2	CID000142899
Drug	protoporphyrinogen	CPOX PPOX	2.22e-04	3	197	2	ctd:C011539
Drug	Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A	GADD45B ABCA12 ITPR1 LPIN1 ZFYVE9 HSPG2 AFAP1 PDE4DIP	2.32e-04	187	197	8	5396_UP
Drug	Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A	NOX5 MYOC ITPR1 PLTP CSTF2T VCAN IL1RAP PCK1	2.32e-04	187	197	8	4364_UP
Drug	Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A	MAP4 DDN MPDZ ACAN RUNX2 IFIT2 IGHMBP2 PDE4DIP	2.49e-04	189	197	8	3084_UP
Drug	genistein; Up 200; 10uM; HL60; HT_HG-U133A	TECPR2 CACNA1G IL17RB ADAM22 KMT2D PHF3 TLE3 PDE4DIP	2.49e-04	189	197	8	2695_UP
Drug	Sistan	ZNF185 SLC30A3 PPOX VCAN	2.58e-04	36	197	4	CID003001858
Drug	Acacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A	DACH1 BBS9 AGL PDS5A DIDO1 FAAP100 PDE4DIP IL1RAP	2.59e-04	190	197	8	2189_DN
Drug	Econazole nitrate [24169-02-6]; Up 200; 9uM; PC3; HT_HG-U133A	GADD45B THSD1 LILRB1 ACAN NID2 IFIT2 VCAN IL1RAP	2.59e-04	190	197	8	7305_UP
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; HL60; HT_HG-U133A	MAP4 BBS9 LILRB1 ZFYVE9 DNMBP HSPG2 VCAN HDLBP	2.59e-04	190	197	8	1342_UP
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	MYO1C MAP4 LILRB1 ZFYVE9 AHNAK DNMBP PDE4DIP SNRNP200	2.68e-04	191	197	8	2937_DN
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A	MAP4 THSD1 BBS9 CSTF2T ARHGEF12 ADAM22 TRAK1 IL1RAP	2.87e-04	193	197	8	4161_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	BCAS3 PALMD BBS9 ITPR1 ZFYVE9 ACAN AHNAK SZT2	2.87e-04	193	197	8	3773_DN
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	DENND4A MCC PALMD BFSP1 PHC3 VCAN PDE4DIP IL1RAP	2.87e-04	193	197	8	5119_DN
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	THSD1 PHC3 WDR62 DSCAM ARHGEF12 PDE4DIP FLCN CABIN1	2.87e-04	193	197	8	5315_UP
Drug	retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A	MAP4 BCAS3 THSD1 BBS9 EHBP1L1 IL17RB TLE3 PDE4DIP	2.98e-04	194	197	8	1211_DN
Drug	Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A	MYOC PCDH12 SLC30A3 LPIN1 NHLH2 DOP1B KMT2D PHF3	2.98e-04	194	197	8	6457_UP
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A	MAP1A THSD1 BBS9 ACAN CSTF2T TRAK1 VCAN IL1RAP	2.98e-04	194	197	8	6660_DN
Drug	Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; HL60; HT_HG-U133A	GADD45B ZFYVE9 ABCC10 COL7A1 FAAP100 PHF3 IGHMBP2 FLCN	2.98e-04	194	197	8	1858_DN
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	DDN PALMD BFSP1 ITPR1 CSTF2T IFIT2 AFAP1 IL1RAP	2.98e-04	194	197	8	4455_DN
Drug	5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA	GBF1 ABCA12 THSD1 ITPR1 ZFYVE9 TECPR2 PHF3 PDE4DIP	3.08e-04	195	197	8	834_UP
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MAP4 LPIN1 EHBP1L1 TECPR2 PLTP DOP1B HSPG2 NCOR2	3.08e-04	195	197	8	5265_UP
Drug	Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	DENND4A MCC DDN MPDZ COL7A1 ARHGEF12 TRAK1 CEP135	3.08e-04	195	197	8	5797_DN
Drug	Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A	DDN PDS5A DHX35 DOP1B ARHGEF12 FAAP100 NCOR2 IGHMBP2	3.08e-04	195	197	8	7372_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; HL60; HG-U133A	DENND4A MYO1C ACAN AHNAK IFT57 BCAN CPOX KCTD3	3.08e-04	195	197	8	1431_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; HL60; HG-U133A	GBF1 ZFYVE9 ACAN AHNAK ABCC10 IFIT2 TLE3 ATP6V0A2	3.08e-04	195	197	8	1371_DN
Drug	Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MAP4 MCC BFSP1 ACAN WDR62 HSPG2 IGHMBP2 PDE4DIP	3.08e-04	195	197	8	7022_UP
Drug	Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	MAP1A SLC30A3 SVIL DOP1B BCAN ADAM22 NCOR2 PCDH8	3.08e-04	195	197	8	4424_UP
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A	DDN BBS9 BFSP1 PHC3 TECPR2 WDR62 ARHGEF12 BCAN	3.08e-04	195	197	8	6626_DN
Drug	5286656; Up 200; 50uM; MCF7; HT_HG-U133A_EA	MAP4 SLC30A3 LILRB1 EHBP1L1 AMH AFAP1 VCAN FLCN	3.08e-04	195	197	8	889_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	GBF1 MAP4 MPDZ BBS9 ABCC10 WDR62 TRAK1 FLCN	3.19e-04	196	197	8	7226_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A	MAP4 PALMD ACAN AHNAK COL7A1 DSCAM ADAM22 NCOR2	3.19e-04	196	197	8	3745_UP
Drug	Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A	MAP4 ABCA12 THSD1 BBS9 BFSP1 HSPG2 PHF3 BTBD7	3.19e-04	196	197	8	2236_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	GBF1 MAP1A BBS9 ITPR1 DNMBP DIDO1 CABIN1 HDLBP	3.19e-04	196	197	8	1821_DN
Drug	Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	GBF1 MAP4 ZFYVE9 DIDO1 PHF3 BTBD7 IGHMBP2 CABIN1	3.19e-04	196	197	8	1487_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	ABCA12 SLC30A3 ITPR1 PLTP SZT2 ADAM22 PHF3 PDE4DIP	3.19e-04	196	197	8	5583_UP
Drug	Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A	CSTF2T HSPG2 COL7A1 ADAM22 AFAP1 IGHMBP2 PDE4DIP CABIN1	3.19e-04	196	197	8	3881_DN
Drug	Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A	DENND4A BBS9 ZFYVE9 WDR62 AFAP1 PHF3 FLCN IL1RAP	3.19e-04	196	197	8	1820_UP
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A	MAP4 MCC LPIN1 PHC3 SZT2 BCAN TLE3 PDE4DIP	3.19e-04	196	197	8	6602_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; HL60; HG-U133A	ACACA MAP4 FKTN DIDO1 TRAK1 TLE3 CABIN1 ATP6V0A2	3.19e-04	196	197	8	1373_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MYO1C DACH1 THSD1 BBS9 BFSP1 DHX35 ROBO3 DSCAM	3.19e-04	196	197	8	2225_DN
Drug	N,N-diethylbenzamide	PPAN ACACA ACAN PCDH8	3.19e-04	38	197	4	CID000015542
Drug	Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A	MAP4 DACH1 PCDH12 EHBP1L1 ZFYVE9 HSPG2 ARHGEF12 PDE4DIP	3.30e-04	197	197	8	5349_UP
Drug	S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A	MYOC SLC30A3 ITPR1 PHC3 ACAN ADAM22 PDE4DIP DCHS1	3.30e-04	197	197	8	6471_UP
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAP4 BBS9 ITPR1 EHBP1L1 CSTF2T DSCAM BTBD7 CABIN1	3.30e-04	197	197	8	2307_DN
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A	PALMD ZFYVE9 ACAN DOP1B COL7A1 ADAM22 NCOR2 PCK1	3.30e-04	197	197	8	3719_UP
Drug	Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A	MAP4 DACH1 BBS9 PHC3 IL17RB LARS2 PDE4DIP FLCN	3.30e-04	197	197	8	1671_DN
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	ITPR1 EHBP1L1 ROBO3 BCAN ADAM22 PHF3 IGHMBP2 CABIN1	3.30e-04	197	197	8	5643_DN
Drug	Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; MCF7; HT_HG-U133A	MAP4 BBS9 TECPR2 AHNAK WDR62 NCOR2 BTBD7 IGHMBP2	3.30e-04	197	197	8	3401_DN
Drug	estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A	DACH1 LILRB1 SVIL PLTP COL7A1 DIDO1 LARS2 IGHMBP2	3.30e-04	197	197	8	1149_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ABCA12 THSD1 BBS9 PHC3 WDR62 RUNX2 ADAM22 IGHMBP2	3.30e-04	197	197	8	7405_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	MAP4 DACH1 CSTF2T HSPG2 LARS2 FAAP100 BTBD7 PDE4DIP	3.30e-04	197	197	8	1640_DN
Drug	Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A	DENND4A MAP4 DHX35 ADAM22 TLE3 PDE4DIP FLCN CABIN1	3.30e-04	197	197	8	5314_UP
Drug	Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MAP4 ZFYVE9 ROBO3 IL17RB ADAM22 NCOR2 IGHMBP2 PDE4DIP	3.41e-04	198	197	8	7471_UP
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A	DACH1 ZFYVE9 DHX35 TRAK1 PHF3 PDE4DIP CABIN1 IL1RAP	3.41e-04	198	197	8	3441_DN
Drug	Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; HL60; HT_HG-U133A	MAP4 LILRB1 EHBP1L1 ZFYVE9 TECPR2 AHNAK DNMBP SZT2	3.41e-04	198	197	8	2336_UP
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	MYO1C MAP4 BBS9 SVIL AFAP1 PDE4DIP FLCN IL1RAP	3.41e-04	198	197	8	2080_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A	DENND4A MAP4 BBS9 EHBP1L1 DIDO1 TRAK1 BTBD7 IGHMBP2	3.41e-04	198	197	8	3479_UP
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	LILRB1 ACAN CACNA1G DOP1B HSPG2 KIF26B PDE4DIP PCDH8	3.41e-04	198	197	8	4230_UP
Disease	triacylglycerol 58:9 measurement	GBF1 CPOX PTPRT TNXB	1.11e-05	22	190	4	EFO_0010443
Disease	Down syndrome (implicated_via_orthology)	DOP1B DSCAM DOP1A	1.13e-04	15	190	3	DOID:14250 (implicated_via_orthology)
Disease	myoglobinuria (implicated_via_orthology)	LPIN1 LPIN3	1.23e-04	3	190	2	DOID:0080108 (implicated_via_orthology)
Disease	Disorder of eye	MYOC BBS9 GPR179 PCDH15 VCAN VSX2 SNRNP200	4.68e-04	212	190	7	C0015397
Disease	airway responsiveness measurement	BCAS3 PCDH15 WDFY4	4.81e-04	24	190	3	EFO_0006897
Disease	intraocular pressure measurement	BCAS3 MYOC BBS9 PKHD1 HERC2 TTF2 ARHGEF12 RUNX2 AFAP1 TNXB HDLBP	4.93e-04	509	190	11	EFO_0004695
Disease	glaucoma	BCAS3 MYOC PKHD1 HERC2 ARHGEF12 AFAP1	5.03e-04	154	190	6	MONDO_0005041
Disease	Herpetic meningoencephalitis	IRF3 TBK1	6.08e-04	6	190	2	C0019385
Disease	Glaucoma	MYOC WDR36	6.08e-04	6	190	2	cv:C0017601
Disease	ergothioneine measurement	MPDZ LNX1 SLC22A16	6.13e-04	26	190	3	EFO_0021163
Disease	Colorectal Carcinoma	CPAMD8 ACACA ABCA12 MCC LPIN1 PKHD1 COL7A1 PTPRT PPOX DCHS1 FLCN CDH5 SNRNP200	6.65e-04	702	190	13	C0009402
Disease	Herpes encephalitis	IRF3 TBK1	8.48e-04	7	190	2	C0276226
Disease	serum gamma-glutamyl transferase measurement	MAP1A MCC SLC30A3 ITPR1 AHNAK SVIL PKHD1 DNMBP PLTP AMH ARHGEF19 FAAP100 NCOR2 CABIN1 HDLBP	8.97e-04	914	190	15	EFO_0004532
Disease	Glaucoma	CPAMD8 MYOC	1.44e-03	9	190	2	C0017601
Disease	mean arterial pressure	MAP4 NOX5 CEP170 TTBK1 PKHD1 PDS5A LNX1 ABCC10 SZT2 ARHGEF12	1.55e-03	499	190	10	EFO_0006340
Disease	Malignant neoplasm of breast	NET1 HNRNPK MAGED2 FKTN HERC2 SPOCD1 NID2 COL7A1 UTS2R B3GALNT2 KMT2D TLE3 CDH5 PCDH8 DOP1A HDLBP	1.66e-03	1074	190	16	C0006142
Disease	osteoarthritis, hand	SNAP47 CFAP54 TTF2	1.74e-03	37	190	3	EFO_1000789
Disease	forced expiratory volume	BCAS3 BBS9 ACAN AGL AHNAK PCDH15 DSCAM CPOX LARS2 NCOR2 IGHMBP2 AGMO TNXB	1.90e-03	789	190	13	EFO_0004314
Disease	response to ondansetron, QT interval	MPDZ LNX1	2.18e-03	11	190	2	EFO_0004682, EFO_0020997
Disease	nucleus accumbens volume change measurement	DSCAM MUC16	2.18e-03	11	190	2	EFO_0021493
Disease	Pancreatic Ductal Adenocarcinoma	ABCA12 ADAM11	2.18e-03	11	190	2	C1335302
Disease	cataract	CPAMD8 FKTN HERC2 DNMBP AGMO	2.24e-03	141	190	5	MONDO_0005129
Disease	open-angle glaucoma (is_implicated_in)	MYOC AFAP1	2.61e-03	12	190	2	DOID:1067 (is_implicated_in)
Disease	Secondary Open Angle Glaucoma	MYOC WDR36	2.61e-03	12	190	2	C0271148
Disease	intracranial aneurysm (is_implicated_in)	KMT2D VCAN	2.61e-03	12	190	2	DOID:10941 (is_implicated_in)
Disease	brain disease (is_implicated_in)	IRF3 TBK1	2.61e-03	12	190	2	DOID:936 (is_implicated_in)
Disease	Glaucoma, Open-Angle	MYOC WDR36	2.61e-03	12	190	2	C0017612
Disease	fibromuscular dysplasia	SVIL FRMPD2B LNX1	2.87e-03	44	190	3	EFO_1000938
Disease	Hypoxanthine measurement	ERCC5 PKHD1	3.07e-03	13	190	2	EFO_0021604
Disease	ximenoylcarnitine (C26:1) measurement	SLC22A16 IGHMBP2	3.07e-03	13	190	2	EFO_0800543
Disease	cerotoylcarnitine (C26) measurement	SLC22A16 IGHMBP2	3.07e-03	13	190	2	EFO_0800542
Disease	Glaucoma, Primary Open Angle	MYOC WDR36	3.07e-03	13	190	2	C0339573
Disease	dimethylglycine measurement	ERCC5 UFSP2 CACNA1G	3.25e-03	46	190	3	EFO_0010476
Disease	Squamous cell carcinoma of esophagus	FAT2 DIDO1 KMT2D TNXB	3.36e-03	95	190	4	C0279626
Disease	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	FKTN B3GALNT2	3.57e-03	14	190	2	C1836373
Disease	alpha-Dystroglycanopathies	FKTN B3GALNT2	3.57e-03	14	190	2	C2936406
Disease	glycodeoxycholate measurement	SVIL COL7A1	3.57e-03	14	190	2	EFO_0010493
Disease	Fukuyama Type Congenital Muscular Dystrophy	FKTN B3GALNT2	3.57e-03	14	190	2	C0410174
Disease	triacylglycerol 48:4 measurement	DACH1 DSCAM	3.57e-03	14	190	2	EFO_0010407
Disease	Muscle eye brain disease	FKTN B3GALNT2	3.57e-03	14	190	2	C0457133
Disease	Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1	FKTN B3GALNT2	3.57e-03	14	190	2	C4284790
Disease	Alzheimer disease, dementia, family history of Alzheimer’s disease	MPDZ LNX1 FHOD3	3.67e-03	48	190	3	EFO_0009268, MONDO_0001627, MONDO_0004975
Disease	hypertension	MCC PHC3 TTBK1 SZT2 ARHGEF12 NCOR2 TNXB	3.88e-03	307	190	7	EFO_0000537
Disease	neuroimaging measurement	BBS9 EFTUD2 AHCY PKHD1 CAMTA1 ROBO3 LNX1 SZT2 KIF26B ARHGEF12 FRYL BCAN RUNX2 AFAP1 VCAN	4.03e-03	1069	190	15	EFO_0004346
Disease	Walker-Warburg congenital muscular dystrophy	FKTN B3GALNT2	4.10e-03	15	190	2	C0265221
Disease	ovarian carcinoma (is_implicated_in)	AMH CABIN1	4.10e-03	15	190	2	DOID:4001 (is_implicated_in)
Disease	Autosomal recessive primary microcephaly	WDR62 CEP135	4.10e-03	15	190	2	cv:C3711387
Disease	Hypertriglyceridemia	PLTP LIPI	4.10e-03	15	190	2	C0020557
Disease	lipid metabolism disorder (implicated_via_orthology)	LPIN1 LPIN3	4.10e-03	15	190	2	DOID:3146 (implicated_via_orthology)
Disease	serum albumin measurement	MAP1A MAP4 MCC EHBP1L1 CPT1C LNX1 COL7A1 ARHGEF19 FRMD5 HDLBP	5.23e-03	592	190	10	EFO_0004535
Disease	response to radiation, Urinary retention	CAMTA1 AGMO	5.26e-03	17	190	2	GO_0009314, HP_0000016
Disease	sexual dimorphism measurement	ANKRD31 GADD45B ZNF346 SNAP47 EHBP1L1 ACAN AHCY SPOCD1 PLTP COL7A1 FRYL FAM83C NCOR2 ATP6V0A2 HDLBP	5.48e-03	1106	190	15	EFO_0021796
Disease	Tourette syndrome, schizophrenia	YJEFN3 PHF3	5.90e-03	18	190	2	EFO_0004895, MONDO_0005090
Disease	obsolete_red blood cell distribution width	BCAS3 PLEKHG5 BBS9 IQGAP1 CEP170 EHBP1L1 HECW2 PDS5A OXSR1 PLTP APEH KBTBD2 ZFAND4 SLC22A16 ADGRD2 VSX2 FRMD5	6.44e-03	1347	190	17	EFO_0005192

Protein segments in the cluster

Peptide	Gene	Start	Entry
GVELGEESRSSPLKL	TACC1	306	O75410
ATTPGSAIDTREELV	CEP170	1341	Q5SW79
DRSSLRTLGSVGEPI	ACSS1	406	Q9NUB1
TLRLSEILESLGSPG	CFAP54	671	Q96N23
LSTTLDGGRKIPETT	CAMTA1	466	Q9Y6Y1
RTVSISEGPDTLGDG	ATG16L2	231	Q8NAA4
LTEDEASSTGGREPV	ANKLE1	336	Q8NAG6
TLIEILSDTGAEGPT	VCAN	2331	P13611
LDPERIIGATDSSGE	CBX3	121	Q13185
IFGEPLGASTTRISE	ADGRG4	961	Q8IZF6
PGRLDDALTSISAGV	AGMO	66	Q6ZNB7
GSRVVILDEPSTGVD	ABCA12	1496	Q86UK0
LSSERPSSDGEGVVE	AFAP1	276	Q8N556
EVTEPSRLVRESSGG	ADAM11	46	O75078
IPRLGELDGEITSTL	ADAM22	611	Q9P0K1
SGTIRQGEELPSEEL	ARHGEF35	201	A5YM69
RESRGSVLEPEGTVE	ACACA	2111	Q13085
PAVDISSSLGGRAVE	AHNAK	276	Q09666
DEDISRTSGPSVAGL	DOP1A	2261	Q5JWR5
LLGPLRTVDESVSSG	DNMBP	201	Q6XZF7
PGDSTLEERTFRILG	DDN	536	O94850
TGTLPSGVTEDDVAI	BCAS3	291	Q9H6U6
LTPEIEADRSGGRTD	DACH1	726	Q9UI36
VVPEDTRVGTSVGSL	CDH5	266	P33151
ISGSEILGPTLSETR	FAM193A	551	P78312
VTGLQSPDRDLGLES	ARHGEF12	1171	Q9NZN5
TTGKPIEASIRGELS	ANXA6	221	P08133
RSGLGSPTDIKTVRE	CFAP206	141	Q8IYR0
LGEVPTIESLIGESS	IQGAP1	1331	P46940
EPEEATLTSVLRSGA	NWD1	131	Q149M9
RSISTSGPLDKEDTG	DENND4A	1586	Q7Z401
SIQVDGEELVSGRSP	HSPG2	4306	P98160
EGIDEPLASGVTITS	PCK1	371	P35558
EEEGVSPDTAIRSGL	PDS5A	646	Q29RF7
GGPTIETLELQSERS	NOBOX	331	O60393
TGSGSIDPDELRTVL	NOX5	136	Q96PH1
PIQVDSEEGLLSTGR	PCDH12	76	Q9NPG4
PGRDTAEGVSQELIS	OXSR1	456	O95747
DLLTRIGEATKPDGT	NET1	231	Q7Z628
PRVELSGSTRVSLEG	ARHGEF19	176	Q8IW93
GEISRTVTSEKPAGL	ANKRD36C	811	Q5JPF3
LSEGRDSPEVSLLSG	ANKRD31	151	Q8N7Z5
EGTPGLVRLSSDADL	HECW2	1121	Q9P2P5
RASLGIAGPETELVD	PCDHA7	681	Q9UN72
PSTLVEAREVGEATG	BCAN	556	Q96GW7
IEGEPTSSLTAGRKE	MUC16	4591	Q8WXI7
EITTLVSRGAGDVPR	MUC16	7366	Q8WXI7
PGVLTSLVTSSGRDI	MUC16	11316	Q8WXI7
PTGEALNLLGTDSER	ABCC10	376	Q5T3U5
GTITRIIGEDSPSRL	NCOR2	1241	Q9Y618
TTGDGTEDPSLTALR	PALMD	526	Q9NP74
DRGSPALVGSATLTV	DCHS1	2251	Q96JQ0
PSGLFELDESSGTLR	DCHS1	2646	Q96JQ0
ESSVVLEGRAGATSP	LPIN3	261	Q9BQK8
LETSGTTSELEGRAP	KIAA0100	706	Q14667
SSGSLVLLDRGDTEP	MDN1	856	Q9NU22
ESETPGERLREGQTL	HAX1	111	O00165
DPEGLSSESGRVERL	MAP1A	2581	P78559
TLEPTDAGILGTTKD	MAGED2	351	Q9UNF1
LSSETSGIARPEEGR	MAP4	661	P27816
GSRLTEKLLEGAPTE	FLCN	266	Q8NFG4
LGVPGAAASRTSEIE	MDP1	61	Q86V88
ETGVPSEESGLLALT	GPR179	2246	Q6PRD1
SIFELDPTTLRGGDS	ITPR1	366	Q14643
TEREVTAPGATTLSG	MUC20	506	Q8N307
DLLLEGVQGESSPTR	RPS6KC1	271	Q96S38
GSLSSPLIDTERNLG	HERC2	1296	O95714
DRDSLPGGIVTDETL	IL1RAP	441	Q9NPH3
TDGSVLRLESPGEAS	HMCN2	1676	Q8NDA2
DGSGTLVSRPGELVT	HMCN2	3326	Q8NDA2
LLPGLEEGSEISDRT	DOP1B	151	Q9Y3R5
LTISGVLDSGRPTSI	KIF26B	1196	Q2KJY2
TRASVVIPVTGDSEG	IL17RB	231	Q9NRM6
DPDDVLTVTESSRGL	LMTK3	461	Q96Q04
ELPRAEGLGTSETAE	BNIPL	146	Q7Z465
EIRRAGPGSEELTVT	KIFC1	486	Q9BW19
EGVSIRTGLELSRDP	PLTP	121	P55058
RDGGTPSLQSEEEVL	FAT2	2146	Q9NYQ8
GATSLVPEGAARESL	PCDH8	396	O95206
SDVLSRLVETVGDPG	FRYL	1846	O94915
TVTRGEGLSPIESCE	DPY19L1	136	Q2PZI1
TQEIASRDSGVPGLE	EHBP1L1	776	Q8N3D4
RLPSGTVDGSSVTVE	KBTBD2	486	Q8IY47
VGEPLTLRTAETITG	MYOC	251	Q99972
DPSESLSIRLVGGSE	LNX1	281	Q8TBB1
VESTSDGLRDLPSIA	LPIN1	451	Q14693
STSLIPGESKDLAGR	GOLGA6L2	156	Q8N9W4
STETETGSRVGKLPE	GABRE	56	P78334
GTEALRAEEPAVGTS	AMH	21	P03971
LREVVGGALAPSDSE	FAAP100	606	Q0VG06
SPAAITVGRGEDLTS	PHC3	616	Q8NDX5
GGCTTIPESDLEERS	BBS9	841	Q3SYG4
DISGLPSGEVLETTA	ACAN	991	P16112
GVEDLSRLPSGEEVL	ACAN	1521	P16112
SRLPSGEEVLEISAS	ACAN	1526	P16112
EISGLPSSELDISGR	ACAN	1691	P16112
GEASGLPEVTLITSE	ACAN	2026	P16112
SDPVKTLGEGLSERT	PTPRQ	1931	Q9UMZ3
TDGSRGELSQPTLTI	PTPRT	831	O14522
SLTSSVPEEGTVGRE	PCDHGA3	351	Q9Y5H0
ISRAGLELGAEPETI	NID2	1166	Q14112
LIITASDGRPDGTST	PCDH15	686	Q96QU1
VALDGGRSPDVLSLE	CEP135	246	Q66GS9
RPSLTSDGAEVELSA	CPT1C	11	Q8TCG5
TPTATEVEALGGELR	FRMD5	466	Q7Z6J6
SSDRPVLGSEISSIG	MCC	341	P23508
AVVTTSGLEDGVPRS	IFT57	6	Q9NWB7
EDTLSELAEGSERPG	CABIN1	1661	Q9Y6J0
SRSTEILGEDLAGPS	DOCK8-AS1	46	Q5T8R8
LGSREDLLAEVSGPS	CACNA1G	2146	O43497
GPDRLSLLSEVTSGT	FAM83C	101	Q9BQN1
GDERTAVSLVTALPG	FRMPD2B	61	Q6IN97
LLGEPAETQGTTEAR	GADD45B	101	O75293
DTTSALVDGLQPGER	FNDC1	416	Q4ZHG4
EGPGVSISEERQSLA	DHX35	16	Q9H5Z1
LSEDTSSGLPEDRVV	B3GALNT2	131	Q8NCR0
DGAEVLGTRSRSLPE	BFSP1	596	Q12934
AIPGSERATASIIGD	CPAMD8	1111	Q8IZJ3
PEEARALGLVGTSEL	FHOD3	1406	Q2V2M9
LSLKGSTETRSLPGE	GCM1	181	Q9NP62
GLEPERIIGATDSSG	CBX1	116	P83916
LATETGEGEGEPLSR	DIDO1	1566	Q9BTC0
PTGLRVAGEAAETDS	BLOC1S3	51	Q6QNY0
GRTAVETDLTFGLTP	BTBD7	1056	Q9P203
RLDGIDSLSGTEIPL	FKTN	146	O75072
EDSERGLESGSLIPS	IFIT2	451	P09913
VIRSEDTTGPITGLA	GBF1	71	Q92538
LLAGGAREPSSDTVV	KLHDC9	46	Q8NEP7
GTARTTALEGPELTI	COL7A1	321	Q02388
DPRGGTLLSVTGEVE	CSTF2T	336	Q9H0L4
RVEGSSKESAGLIPS	MPP1	206	Q00013
EGVTSTSRRIGPELS	EME1	536	Q96AY2
PERRGSLTLTISGES	FAM83H	931	Q6ZRV2
LLPGIRGISEETTTG	AHCY	146	P23526
SGTRATSLGRPEEEE	CPOX	106	P36551
SPGVEIKSLRELDSG	KCTD3	711	Q9Y597
ERSLDPDSGTELGTL	COL5A3	321	P25940
GLSESSDPLELVVTG	LILRA3	106	Q8N6C8
GLLVTGEKEEPSRSA	PPEF2	406	O14830
IVDLITFTEGSGRSP	IRF3	326	Q14653
TGLLIENIRPSDSGS	DSCAM	276	O60469
LSSTRGTGLPAITDV	RUNX2	321	Q13950
DRAEGIEGETLTASP	SZT2	1806	Q5T011
PLVAGSSEEGSRRSL	SLC35D3	371	Q5M8T2
DASVPRTRGEELTGL	SNAP47	156	Q5SQN1
SLTVLEGDGRDSPVL	SVIL	406	O95425
EVIETLPDGTERLSS	LARS2	396	Q15031
EGRPLRTTVFLDTSG	LIPI	316	Q6XZB0
GRSESSDPLELVVTG	LILRB1	106	Q8NHL6
GEEGRISESPEVTRL	PLEKHA4	186	Q9H4M7
GLEKTEAITPRDSGL	SLC22A16	561	Q86VW1
SSGPERILSISADIE	HNRNPK	81	P61978
PLEGSEDRIITITGT	HNRNPK	426	P61978
GTDTKVLGSVSDLEP	NHLH2	26	Q02577
LSTDSGIERDLPTGA	PIK3R6	336	Q5UE93
VGTREGEAPAESESL	ERCC5	686	P28715
EEGLVDDRAPTTTRG	SHPRH	1276	Q149N8
STARDVLESGLSPGK	TRGV3	71	P03979
LITARSVPTEGTEEG	PKHD1	756	P08F94
SVPTEGTEEGSGLVL	PKHD1	761	P08F94
LESISSIDRELSPEG	SCRIB	1221	Q14160
VETRGELLSRESPSG	APEH	86	P13798
GPEEESLLRTLSFVG	ADGRD2	651	Q7Z7M1
LSSTAEGADLRTVDP	ANKHD1	126	Q8IWZ3
RLSTEPSSEALGVGE	ATF6B	106	Q99941
ELAEKGELRSGSLTP	TRAK1	526	Q9UPV9
SLAAVTPIIERESGG	UFSP2	126	Q9NUQ7
SELGLDSEVLPVRGD	PPOX	76	P50336
GASPEETRQLLLEGS	PLEKHG5	576	O94827
TLGTRGSVISPTELE	VPS52	346	Q8N1B4
AEIEGSALSGAPRET	TTBK1	991	Q5TCY1
GAIEERTAPTALGIT	MPDZ	336	O75970
EEASGIPSRTASLEL	PPAN	361	Q9NQ55
LLRDLPGVAATEETG	IGHMBP2	471	P38935
GEKLGTTSSVPILDR	SPATA31D1	971	Q6ZQQ2
REPLGGLSSSLDTEA	SPOCD1	391	Q6ZMY3
ERELPEGISTSSLEV	SYCP2L	681	Q5T4T6
GLGAESLSVTRSIPE	ROBO3	751	Q96MS0
LLGRDSVITSTGPID	THSD1	221	Q9NS62
VDPSGGRATLLESIR	WASH2P	356	Q6VEQ5
LAGPSSDLRAEGTVI	ZSCAN1	221	Q8NBB4
SDLRAEGTVISSPKG	ZSCAN1	226	Q8NBB4
GELTVTDITPDSVGL	TNXB	1581	P22105
DSETLGRVAESGLPA	WDFY4	151	Q6ZS81
ETGSDSEDGLRPDVL	YJEFN3	236	A6XGL0
TEDLPDSIQVGGRIS	PHF3	1236	Q92576
ISSRPEGLTSTVRDG	TECPR2	351	O15040
EILGLQGSEVTTPDS	TBC1D15	626	Q8TC07
LPDGRTLIVGGEAST	TLE3	541	Q04726
AAGGLETTRLVSPRD	SLC30A3	6	Q99726
ARISRSISLGDSEGP	WDR62	1221	O43379
TRRDEPTGEVLSLVG	SNRNP200	31	O75643
EPSSLEDLVATGTIG	UTS2R	41	Q9UKP6
SSSELLEGQEPDGVR	ZNF346	21	Q9UL40
GTVEALESSVRGLPA	PLIN5	296	Q00G26
GSDTVVIRGPSSDVE	HDLBP	696	Q00341
GDVDTSLPRTLDELG	EFTUD2	386	Q15029
AVDRGDGTLTPLSDS	ZFAND4	156	Q86XD8
DESEGRTIELPSGRS	ZNF185	46	O15231
EDLTGKISSPRTDLG	ZFYVE9	291	O95405
ETSLQDIDSRLSPGG	TBK1	516	Q9UHD2
EEVLSGLTLSPEQGT	TTF2	451	Q9UNY4
ALEEGSRESGATIPS	ATP6V0A2	341	Q9Y487
ETELRSLSPDCGGSI	WDR36	856	Q8NI36
LGRVSELTEEPDSGR	WFIKKN2	466	Q8TEU8
LGTVSGPDSLARSTE	VSX2	321	P58304
ATPRDGSAVEIVGLS	AGL	1276	P35573
ELGVSTDVSPARDEG	KMT2D	1241	O14686
RDGTIDFTPGSELLI	MYO1C	1031	O00159
SIPRSTLGDLDTVAG	PDE4DIP	736	Q5VU43
ILDTGTSLITGPTEE	NAPSA	281	O96009
TQTELLSPGSGRAEE	NECTIN4	456	Q96NY8